Pharmacoeconomics of Rheumatic Diseases in the Arab World
Open Access
- 12 July 2026
- book chapter
- Published by Springer Nature
- p. 481-504
Abstract
Pharmacologic therapy constitutes an integral part of managing rheumatologic diseases, with a diversity of available options from simple molecules to complex biologics and a trending rise in the cost of therapy accompanying novel innovations. The application of pharmacoeconomic principles is thus of particular significance regarding drug therapy selection in rheumatology. Additionally, there is current global interest in adopting new health technology assessment models and value-based approaches to care delivery. The Arab world is no different, with potential country-specific roadmaps in draft or the initial phases of implementation involving key stakeholders from regulators, payers, manufacturers, health economists, and healthcare providers. This chapter will define basic concepts in health economics, shed light on rheumatologic disease burden and budget impact, and explore approaches to cost-effective therapies. We conclude with recommendations to support the adoption of biosimilars as cost-effective treatment alternatives, highlight barriers to their adoption, and suggest means to strengthen pharmacovigilance as the way forward.Keywords
Funding Information
- Infomed International For Events S.A.R.L, Dubai, UAE
This publication has 66 references indexed in Scilit:
- 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and ImagingArthritis Care & Research, 2022
- 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisArthritis & Rheumatology, 2021
- 2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity MeasuresArthritis Care & Research, 2019
- 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial SpondyloarthritisArthritis & Rheumatology, 2019
- 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic ArthritisArthritis & Rheumatology, 2018
- Medical Care Costs Associated With Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta‐AnalysisArthritis Care & Research, 2018
- Coverage for High‐Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part DArthritis & Rheumatology, 2015
- Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritisArthritis & Rheumatism, 2011
- Cost‐effectiveness of biologic response modifiers compared to disease‐modifying antirheumatic drugs for rheumatoid arthritis: A systematic reviewArthritis Care & Research, 2010
- Socioeconomic impact of osteoarthritis in Hong Kong: Utilization of health and social services, and direct and indirect costsArthritis Care & Research, 2003